Angiotensin-converting enzyme gene I/D polymorphism and renal disease

被引:28
作者
Navis, G
van der Kleij, FGH
de Zeeuw, D
de Jong, PE
机构
[1] Univ Groningen Hosp, Dept Internal Med, Inst Drug Explorat, Div Nephrol,Dept Clin Pharmcol, NL-9700 RB Groningen, Netherlands
[2] Univ Groningen, NL-9700 RB Groningen, Netherlands
来源
JOURNAL OF MOLECULAR MEDICINE-JMM | 1999年 / 77卷 / 11期
关键词
ACE I/D polymorphism; genetic polymorphism; renal disease; ACE inhibitors; progressive renal disease;
D O I
10.1007/s001099900063
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
In recent years a vast amount of data has been published on the association between the insertion/deletion (VD) polymorphism of the gene coding for angiotensin-converting enzyme and renal disease. It has be come clear that the polymorphism does not affect the prevalence of renal disease. However, data on the association with progression of renal disease and therapy response are still contradictory. Moreover, sufficient data on the physiological significance of this polymorphism are still lacking. This contribution provides an overview of the available studies and the potential pitfalls in interpreting the data. We also discuss the putative mechanisms for the association between the DD genotype and progression of renal disease and suggest directions for the future that might be employed to further clarify the role in renal pathophysiology.
引用
收藏
页码:781 / 791
页数:11
相关论文
共 124 条
  • [1] ACE gene polymorphism: Ischemic heart disease and longevity in 10150 individuals - A case-referent and retrospective cohort study based on the Copenhagen City Heart Study
    AgerholmLarsen, B
    Nordestgaard, BG
    Steffensen, R
    Sorensen, TIA
    Jensen, G
    TybjaergHansen, A
    [J]. CIRCULATION, 1997, 95 (10) : 2358 - 2367
  • [2] ALHENCGELAS F, 1991, J LAB CLIN MED, V117, P33
  • [3] THE ANGIOTENSIN-I-CONVERTING ENZYME (KININASE-II) - PROGRESS IN MOLECULAR AND GENETIC-STRUCTURE
    ALHENCGELAS, F
    SOUBRIER, F
    HUBERT, C
    ALLEGRINI, J
    LATTION, AL
    CORVOL, P
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1990, 15 : S25 - S29
  • [4] ALHENCGELAS F, 1983, J LAB CLIN MED, V101, P83
  • [5] ANGIOTENSIN-II CAUSES MESANGIAL CELL HYPERTROPHY
    ANDERSON, PW
    DO, YS
    HSUEH, WA
    [J]. HYPERTENSION, 1993, 21 (01) : 29 - 35
  • [6] THERAPEUTIC ADVANTAGE OF CONVERTING ENZYME-INHIBITORS IN ARRESTING PROGRESSIVE RENAL-DISEASE ASSOCIATED WITH SYSTEMIC HYPERTENSION IN THE RAT
    ANDERSON, S
    RENNKE, HG
    BRENNER, BM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (06) : 1993 - 2000
  • [7] APPERLOO AJ, 1994, KIDNEY INT, V45, pS174
  • [8] Association of the angiotensin I converting enzyme gene deletion polymorphism with early onset of ESRF in PKD1 adult polycystic kidney disease
    Baboolal, K
    Ravine, D
    Daniels, J
    Williams, N
    Holmans, P
    Coles, GA
    Williams, JD
    [J]. KIDNEY INTERNATIONAL, 1997, 52 (03) : 607 - 613
  • [9] BARLEY J, 1994, J HYPERTENS, V12, P955
  • [10] Evaluation of risk factors for the development of nephropathy in patients with IDDM: Insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control
    Barnas, U
    Schmidt, A
    Illievich, A
    Kiener, HP
    Rabensteiner, D
    Kaider, A
    Prager, R
    Abrahamian, H
    Irsigler, K
    Mayer, G
    [J]. DIABETOLOGIA, 1997, 40 (03) : 327 - 331